ArticleNeurotrauma reports
Perioperative Discontinuation of Antiplatelet and Anticoagulation Therapy in Chronic Subdural Hematoma: Impact on in-Hospital Mortality, Functional Outcome, and Recurrence.
Article in Neurotrauma reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was to evaluate the effect of perioperative discontinuation of antiplatelet and anticoagulation therapy (AAT) on in-hospital mortality, functional outcome, and recurrence in patients with chronic subdural hematoma (CSDH) with prior AAT use, compared to patients without AAT. We retrospectively analyzed data from patients with symptomatic CSDH who underwent surgery in our department between June 2012 and December 2023. Prior AAT was discontinued at hospital admission and reinitiated 3 weeks postoperatively if CSDH resolution was complete. Clinical and neurological status at admission and discharge were assessed using the modified Rankin Scale, with scores >3 defined as a poor outcome. Among 852 surgically treated CSDH patients (mean age 75.2 years; female-to-male ratio 1:2.1), univariate analysis revealed that prior AAT use was significantly associated with higher in-hospital mortality (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.